Timboligue, Bernadette M.

HRN: 28-56-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/20/2026
03/26/2026
ORAL
3cc
TID
Oral Candidiasis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: